Skip to main content
Roivant Sciences Ltd. logo

Roivant Sciences Ltd. — Investor Relations & Filings

Ticker · ROIV ISIN · BMG762791017 LEI · 549300DL466NY5J6U724 US Manufacturing
Filings indexed 859 across all filing types
Latest filing 2026-04-02 Regulatory Filings
Country BM Bermuda
Listing US ROIV

About Roivant Sciences Ltd.

http://roivant.com/

Roivant Sciences is a biopharmaceutical company that develops and commercializes medicines and technologies. The company operates a unique model by building agile, focused subsidiary companies known as 'Vants' to advance specific assets. This structure is designed to accelerate the discovery, development, and delivery of innovative treatments to patients through efficient capital allocation and execution. Roivant employs technology, including artificial intelligence for drug discovery and protein design, across its operations. The company's portfolio spans multiple therapeutic areas, such as autoimmune and pulmonary diseases, and includes commercial-stage products like Vtama for psoriasis and atopic dermatitis, alongside a broad pipeline of investigational drugs.

Recent filings

Filing Released Lang Actions
8-K - Roivant Sciences Ltd. (0001635088) (Filer)
Regulatory Filings
2026-04-02 English
SCHEDULE 13G/A - Roivant Sciences Ltd. (0001635088) (Subject)
Major Shareholding Notification
2026-03-27 English
4 - Roivant Sciences Ltd. (0001635088) (Issuer)
Director's Dealing
2026-03-25 English
4 - Roivant Sciences Ltd. (0001635088) (Issuer)
Director's Dealing
2026-03-25 English
8-K/A - Roivant Sciences Ltd. (0001635088) (Filer)
Regulatory Filings
2026-03-23 English
4 - Roivant Sciences Ltd. (0001635088) (Issuer)
Director's Dealing
2026-03-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.